Department of Biotechnology, KLE Technological University, Hubballi, India.
Department of Mechanical Engineering, College of Engineering, King Khalid University, Abha, Kingdom of Saudi Arabia.
J Biomol Struct Dyn. 2023;41(22):12610-12619. doi: 10.1080/07391102.2023.2167118. Epub 2023 Jan 18.
is one of the leading opportunistic pathogens that causes nosocomial pneumonia and mostly in people with cystic fibrosis. In the present study, an approach was adopted to identify the novel drug target against by employing subtractive genomics and molecular docking studies. Each step in the subtractive genomics scrutinized the bacterial proteome and determined a potential drug target against . 71 essential proteins were obtained from the subcellular localization method that resides in the extracellular region. Metabolic pathways were studied to elucidate the unique pathways where the involvement of proteins present in the pathogen was predicted and a total of 6 unique pathways were determined. By, Genome mining of the source organism 9 ligands were obtained. The molecular docking analysis between the binding site of target protein NDK and ligands was carried out by employing the AutoDock Vina tool. Based on the highest binding affinity, Paenibactin, AnabaenopeptinNZ857 and Nostamide A complex with NDK protein with a lower binding energy of -7.5 kcal/mol, -7.4and -7.2 kcal/molrespectively were considered for the simulation studies. Molecular dynamics simulation studies showed the ligand in complex with protein was highly stable and rigid for a duration of 150 ns. For Paenibactin, AnabaenopeptinNZ857 and Nostamide Acomplex with protein, RMSD plot showed a deviation of ∼0.2-0.3 nm till ∼30ns/50 ns-110ns and further stabilized. The radius of the gyration plot clearly showed that the values stayed at ∼1.45 nm- 1.55 nm showing compactness and stability. The SASA stayed at the range ∼80nm and at least one total number of hydrogen bonds was shown throughout the 150 ns simulation for all three possible ligand-protein complexes. In the RMSF plot, the maximum fluctuation was ranged from ∼0.4-0.42 nm at the range between ∼57ns-60ns.The Paenibactin, AnabaenopeptinNZ857 and Nostamide A complex with NDK protein showed a stable, rigid and compact interaction throughout the simulation of duration 150 ns.Communicated by Ramaswamy H. Sarma.
铜绿假单胞菌是一种主要的机会性病原体,可引起医院获得性肺炎,主要发生在囊性纤维化患者中。在本研究中,采用消减基因组学和分子对接研究的方法,确定了针对铜绿假单胞菌的新型药物靶点。消减基因组学的每一步都对细菌蛋白质组进行了分析,并确定了针对铜绿假单胞菌的潜在药物靶点。通过亚细胞定位方法获得了 71 种存在于细胞外区的必需蛋白,这些蛋白可能成为药物靶点。代谢途径的研究阐明了涉及病原体中存在的蛋白质的独特途径,共确定了 6 条独特的途径。通过对源生物体的基因组挖掘,获得了 9 种配体。采用 AutoDock Vina 工具对靶蛋白 NDK 的结合位点与配体之间进行分子对接分析。基于最高结合亲和力,与 NDK 蛋白结合的 Paenibactin、AnabaenopeptinNZ857 和 Nostamide A 复合物具有较低的结合能-7.5 kcal/mol、-7.4 和-7.2 kcal/mol,分别考虑用于模拟研究。分子动力学模拟研究表明,配体与蛋白质复合物在 150 ns 的时间内高度稳定和刚性。对于 Paenibactin、AnabaenopeptinNZ857 和 Nostamide A 与蛋白质的复合物,RMSD 图显示在大约 30ns/50ns-110ns 之前,偏差约为 0.2-0.3nm,然后进一步稳定。旋转半径图清楚地表明,在整个 150 ns 的模拟过程中,值保持在约 1.45nm-1.55nm,表现出紧凑性和稳定性。在 SASA 中,在至少一个氢键总数在整个 150 ns 的模拟过程中都保持在 80nm 左右。在 RMSF 图中,最大波动范围在 57ns-60ns 之间,约为 0.4-0.42nm。在整个 150 ns 的模拟过程中,Paenibactin、AnabaenopeptinNZ857 和 Nostamide A 与 NDK 蛋白的复合物表现出稳定、刚性和紧凑的相互作用。由 Ramaswamy H. Sarma 传达。